Impact of coffee on liver diseases: a systematic review. (15th September 2013)

• Record Type: Journal Article
• Authors: Saab, Sammy; Mallam, Divya; Cox, Gerald A.; Tong, Myron J.
• Is Part Of: Liver international. Volume 34:Number 4(2014:May)
• Page Start: 495
• Page End: 504
• Publication Date: 2013-09-15
• Subjects: Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.12304
• Languages: English
• ISSNs: 1478-3223

Abstract

<abstract abstract-type="main" id="liv12304-abs-0001"> <title>Abstract</title> <sec id="liv12304-sec-0001" sec-type="section"> <p>Coffee is one of the most commonly consumed beverages in the world. Its health benefits including improved overall survival have been demonstrated in a variety of disease states. To examine the association of coffee consumption with liver disease, a systematic review of studies on the effects of coffee on liver associated laboratory tests, viral hepatitis, nonalcoholic fatty liver disease (NAFLD), cirrhosis and hepatocellular carcinoma (HCC) was performed. Coffee consumption was associated with improved serum gamma glutamyltransferase, aspartate aminotransferase and alanine aminotransferase values in a dose dependent manner in individuals at risk for liver disease. In chronic liver disease patients who consume coffee, a decreased risk of progression to cirrhosis, a lowered mortality rate in cirrhosis patients, and a lowered rate of HCC development were observed. In chronic hepatitis C patients, coffee was associated with improved virologic responses to antiviral therapy. Moreover, coffee consumption was inversely related to the severity of steatohepatitis in patients with non‐alcoholic fatty liver disease. Therefore, in patients with chronic liver disease, daily coffee consumption should be encouraged.</p> </sec> </abstract>